EXHIBIT 99.2 LC ACQUISITION CORP. SUBSCRIPTION AGREEMENT LC Acquisition Corp. c/o Union Square Partners, Ltd. 200 Park Avenue South New York, New York 10003 Ladies and Gentlemen: The undersigned subscriber or subscribers (hereinafter the "Investor")...Subscription Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account) • California
Contract Type FiledDecember 21st, 2001 Company Industry Jurisdiction
EXHIBIT 99.3 LC ACQUISITION CORP. SUBSCRIPTION AGREEMENT LC Acquisition Corp. c/o Union Square Partners, Ltd. 200 Park Avenue South New York, New York 10003 Ladies and Gentlemen: The undersigned subscriber or subscribers (hereinafter the "Investor")...Subscription Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account) • California
Contract Type FiledDecember 21st, 2001 Company Industry Jurisdiction
EXHIBIT 99.1 LC ACQUISITION CORP. SUBSCRIPTION AGREEMENT LC Acquisition Corp. c/o Union Square Partners, Ltd. 200 Park Avenue South New York, New York 10003 Ladies and Gentlemen: The undersigned subscriber or subscribers (hereinafter the "Investor")...Subscription Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account) • California
Contract Type FiledDecember 21st, 2001 Company Industry Jurisdiction
Exhibit 99.1 EXHIBIT 99.1 Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 3 to Schedule 13G need be filed with respect to...Exhibit Agreement • February 13th, 2004 • Mangano Ross J • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 13th, 2004 Company Industry
EXHIBIT 99.6 JOINT FILING AGREEMENT This JOINT FILING AGREEMENT, dated as of December 20, 2001, by and among each of the persons named on the signature pages hereto. WHEREAS, Ross J. Mangano, Troon & Co., an Indiana general partnership and BANKONE...Joint Filing Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account)
Contract Type FiledDecember 21st, 2001 Company Industry
ContractJoint Filing Agreement • February 11th, 2010 • Mangano Ross J • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 11th, 2010 Company IndustryPursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 9 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractJoint Filing Agreement • February 3rd, 2009 • Mangano Ross J • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 3rd, 2009 Company IndustryPursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 8 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractJoint Filing Agreement • February 14th, 2008 • Mangano Ross J • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 14th, 2008 Company IndustryPursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 7 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractJoint Filing Agreement • February 5th, 2007 • Mangano Ross J • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 5th, 2007 Company IndustryPursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 6 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.